Thomas Ciulla

2022

In 2022, Thomas Ciulla earned a total compensation of $936.3K as Former Chief Medical Officer and Chief Development Officer at Clearside Biomedical, a 49% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$150,500
Option Awards$237,791
Salary$430,000
Stock Awards$101,288
Other$16,705
Total$936,284

Ciulla received $430K in salary, accounting for 46% of the total pay in 2022.

Ciulla also received $150.5K in non-equity incentive plan, $237.8K in option awards, $101.3K in stock awards and $16.7K in other compensation.

Rankings

In 2022, Thomas Ciulla's compensation ranked 3,176th out of 5,753 executives tracked by ExecPay. In other words, Ciulla earned more than 44.8% of executives.

ClassificationRankingPercentile
All
3,176
out of 5,753
45th
Division
Manufacturing
1,787
out of 3,133
43rd
Major group
Chemicals And Allied Products
845
out of 1,419
41st
Industry group
Drugs
789
out of 1,320
40th
Industry
Pharmaceutical Preparations
575
out of 966
41st
Source: SEC filing on April 28, 2023.

Ciulla's colleagues

We found two more compensation records of executives who worked with Thomas Ciulla at Clearside Biomedical in 2022.

2022

George Lasezkay

Clearside Biomedical

Chief Executive Officer

2022

Charles Deignan

Clearside Biomedical

Chief Financial Officer

News

You may also like